Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study

References

• AbateS, AssefaZY, TigenehW. Trends of breast cancer in Ethiopia. Int J Cancer Res Mol Mech. 2016;2:2–6.
   Google Scholar
• BizualemS, YalemtsehayM, DanielS, EndegenaA, WondwossenEADWL. Cancer Science & Therapy Biological and Clinicopathological Characteristics of Breast Cancer at. Breast Cancer. 2017;9(12):755–760.
   Google Scholar
• ZhanQ, FuJ, FuF, ZhangJ, WangC. Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis. Oncotarget. 2018;9(2):2739–2751.29416807
   PubMedGoogle Scholar
• Fkih M’hamedI, PrivatM, PonelleF, Penault-LlorcaF, KenaniA, BignonYJ. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. Cell Oncol. 2015;38(6):433–442. doi:10.1007/s13402-015-0239-3
   Web of Science ®Google Scholar
• SiegelRL, MillerKDJA. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.26742998
   PubMed Web of Science ®Google Scholar
• MahletK, KunuzA, TekelechM, et al. National cancer control plan of Ethiopia. In: the situation of cancer in ethiopia. J Cancer Prevent. 2015:13–15.
   Google Scholar
• ChristinaA, DaphneY, LichtensztajnDY, GiordanoSH. SHdI of ACAPWBC. Delayed Initiation of Adjuvant chemotherapy among patients with breast cancer. JAMA Oncol. 2016;2(3):322–329. doi:10.1001/jamaoncol.2015.385626659132
   PubMed Web of Science ®Google Scholar
• DamilaC, LeadndroL, PatriciaXAD. Adjuvant treatment delay in breast cancer patients. Revista da Associação Médica Brasileira. 2015;61(5):411–416.26603003
   PubMed Web of Science ®Google Scholar
• YuK, HuangS, ZhangJ, LiuG, ShaoZ. Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13(1). doi:10.1186/1471-2407-13-240
   Web of Science ®Google Scholar
• PetoR, DaviesC, GodwinJ, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials.The Lancet. 2012;379:432–444.
   PubMed Web of Science ®Google Scholar
• GagliatoDDM, Gonzalez-anguloAM, LeiX, TheriaultRL, GiordanoSH. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J clin oncol. 2014;32:8.
   Web of Science ®Google Scholar
• FarolfiA, ScarpiE, RoccaA, et al. Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer. Eur J Cancer. 2015;51(14):1874–1881. doi:http://dx.doi.10.1016/j.ejca.2015.07.00326206258
   PubMed Web of Science ®Google Scholar
• AlkisN, DurnaliAG, ArslanUY, KocerM. Optimal timing of adjuvant treatment in patients with early breast cancer. Med Oncol. 2011;28:1255–1259.20473647
   PubMed Web of Science ®Google Scholar
• HershmanDL, WangX, McBrideR, JacobsonJS, GrannVR, NeugutAI. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006;99(3):313–321. doi:10.1007/s10549-006-9206-z16583264
   PubMed Web of Science ®Google Scholar
• NurgalievaZZ, FranziniL, MorganRO, VernonSW, LiuCC, DuXL. Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer. Med Oncol. 2013;30:1–9.
   Web of Science ®Google Scholar
• GelmonKA, SpeersC, BarnettJ, OlivottoI. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J clin oncol. 2006;24:245–257.
   Web of Science ®Google Scholar
• WangB, HuangJ, HungW, LinC. Impact on survival on interval between surgery and adjuvant chemotherapy in completely resected stage IB-IIIA lung cancer. PloS one. 2016;4:1–10.
   Google Scholar
• YonS, SusanJ, FainaMS. The effect of delays in treatment for breast cancer metastasis on survival. Br cancer res treatment. 2011;130:953–964.
   Web of Science ®Google Scholar
• RaphaelMJ, BiagiJJ, KongW, MatesM, BoothCM, MackillopWJ. The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2016;160(1):17–28. doi:10.1007/s10549-016-3960-327632288
   PubMed Web of Science ®Google Scholar
• JungSY, SereikaSM, LinkovF, BrufskyA, WeissfeldJL, RosenzweigM. The effect of delays in treatment for breast cancer metastasis on survival. Breast Cancer Res Treat. 2011;130(3):953–964. doi:10.1007/s10549-011-1662-421739101
   PubMed Web of Science ®Google Scholar
• MosalamNA, MohamedH, ElA, SaadAS, MohamedAW. Journal of Oncology Translational Research the impact of adjuvant chemotherapy initiation time on the outcome of breast cancer. Breast Cancer. 2017;3(1):1–8.28232952
   PubMed Web of Science ®Google Scholar
• FedewaSA, WardEM, StewartAK, EdgeSB. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: A National Cohort Study 2004–2006. J Clin Oncol. 2015;28(27):4135–4141.
   Web of Science ®Google Scholar
• VandergriftJL, NilandJC, TheriaultRL, et al. Time to adjuvant chemotherapy for breast cancer in national time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network Institutions. J National Cancer Inst. 2012;105:115.
   Google Scholar
• YuK, FanL, QiuL, LingH, JiangY, ShaoZ. Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent. Oncotarget. 2017;8(28):46549–46556.27447963
   PubMedGoogle Scholar
• SeneviratneS, CampbellI, ScottN, Kuper-hommelM, RoundG, LawrensonR. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study. BMC cancer. 2014;14:1–9.24383403
   PubMed Web of Science ®Google Scholar
• HeX, YeF, ZhaoB, et al. Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: a systematic review and meta-analysis involving 186982 patients. PloS one. 2017;1–12.
   Web of Science ®Google Scholar
• AldermanAK, CollinsED, SchottA, HughesME. The impact of breast reconstruction on the delivery of chemotherapy. PloS one. 2010;1791–1800.
   Google Scholar
• EdgeSB. American Joint Committee on Cancer, American Cancer Society.AJCC CANCER STAGING MANUAL: From the AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
   Google Scholar
• KartalM, TezcanS, CandaT. Diagnosis, treatment characteristics, and survival of women with breast cancer aged 65 and above: a hospital-based retrospective study. BMC Womens Health. 2013;13(1):1–7. doi:10.1186/1472-6874-13-3423295104
   PubMed Web of Science ®Google Scholar
• MaskarinecG, PaganoI, LurieG, BantumE, GotayCC, IssellBF. Factors affecting survival among women with breast cancer in Hawaii. J Women’s Heal. 2011;20(2):231–237.
   Web of Science ®Google Scholar
• PlotogeaA, ChiarelliAM, MireaL, et al. Factors associated with wait times across the breast cancer treatment pathway in Ontario. Plos One. 2013;1–9.
   Google Scholar
• AlessandraF, JanainaV, RefaelM, et al. Análise do tempo decorrido entre diagnóstico e tratamento do câncer de mama. Anal Time Interval. 2018;28(4):6–11.
   Google Scholar
• TaplinBSH, WeaverS, SalasE, et al. Reviewing cancer care team effectiveness. Journal of Oncology Practice. 2015;11(3):239–246. doi:10.1200/JOP.2014.00335025873056
   PubMed Web of Science ®Google Scholar
• AgarwalaV, ChoudharyNGS, GuptaS. A risk-benefit assessment approach to selection of adjuvant chemotherapy in elderly patients with early breast cancer: a mini review. Indian J Med Paediatr Oncol. 2017;38(4):526–534. doi:10.4103/ijmpo.ijmpo_96_1729333024
   PubMed Web of Science ®Google Scholar